Author´s answer: Biosimilar therapy for inflammatory bowel disease

Rev Esp Enferm Dig. 2014 Jan;106(1):67-8. doi: 10.4321/s1130-01082014000100015.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biosimilar Pharmaceuticals / therapeutic use*
  • Humans
  • Inflammatory Bowel Diseases / drug therapy*

Substances

  • Biosimilar Pharmaceuticals